000			01725 a2200445 4500
005			20250516013033.0
264		0	_c20110504
008			201105s 0 0 ger d
022			_a1433-0423
024	7		_a10.1007/s00347-010-2160-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchmitz-Valckenberg, S
245	0	0	_a[Therapy approaches for geographic atrophy]. _h[electronic resource]
260			_bDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft _cNov 2010
300			_a1016-9 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarrier Proteins _xantagonists & inhibitors
650	0	4	_aClinical Trials as Topic
650	0	4	_aComplement Inactivating Agents _xtherapeutic use
650	0	4	_aEye Proteins _xantagonists & inhibitors
650	0	4	_aFenretinide _xtherapeutic use
650	0	4	_aGeographic Atrophy _xblood
650	0	4	_aHumans
650	0	4	_aNeuroprotective Agents _xtherapeutic use
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aReceptor, Serotonin, 5-HT1A _xdrug effects
650	0	4	_aSerotonin Receptor Agonists _xtherapeutic use
650	0	4	_aVision Tests
650	0	4	_aVitamin A _xblood
650	0	4	_acis-trans-Isomerases
700	1		_aMössner, A
700	1		_aFleckenstein, M
700	1		_aWiedemann, P
700	1		_aHolz, F G
773	0		_tDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft _gvol. 107 _gno. 11 _gp. 1016-9
856	4	0	_uhttps://doi.org/10.1007/s00347-010-2160-5 _zAvailable from publisher's website
999			_c20385375 _d20385375